![Action medical technologies at World Vaccine Congress Washington 2024 Action medical technologies at World Vaccine Congress Washington 2024](https://terrapinn-cdn.com/tres/pa-images/10656/a0A4G00001sfd0bUAA_org.jpg?20230313155029)
We're developing first-in-class inhalable and infection-activated RNA therapeutics from COVID-19 and influenza to RSV. Our lead candidate provides single-administration protection against any coronavirus.
USSF located in Allentown, Pennsylvania, Dr. Flanigan is leading his team to bring QYNDR, an oral mucosal vaccine delivery platform currently targeting the COVID-19 vaccine, to market – one that will be easier to use, longer lasting and with fewer...